Semaglutide, suicidal ideation and behaviour: a resting state functional magnetic resonance imaging perspective - Verovnik B, Vovk A.

In recent months, there has been a lot of talk about the use of glucagon-like peptide 1 (GLP-1) receptor agonists, not only in type 2 diabetes but also for its effects on weight loss. Because of its wide use for this purpose and recent reports of suicidal ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news